ReviewCancer gene therapy2026
Reprogramming the tumor microenvironment via TFF3 targeting: a potential novel avenue to boost CAR-T cell therapy in solid tumors.
Arman Rahimi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it